P3.13-11 Advanced NSCLC Treated with Gefitinib or Erlotinib for Five Years or Longer - Retrospective Slovakian Study

Autor:	M. Urda, Peter Kasan, I. Andrasina, P. Berzinec, J. Mazal, Gabriela Chowaniecova, M. Martak, M. Vesela, A. Cipkova, Lukáš Plank
Rok vydání:	2018
Předmět:	Pulmonary and Respiratory Medicine Oncology medicine.medical_specialty Gefitinib business.industry Internal medicine medicine Erlotinib business medicine.drug
Zdroj:	Journal of Thoracic Oncology. 13:S980
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2018.08.1851
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4904a5b5b1973543c9f5c7c4576a47a9 https://doi.org/10.1016/j.jtho.2018.08.1851 Zobrazit plný text záznamu